Advocacy intelligence hub — real-time data for patient organizations
RemeGen Co., Ltd. — PHASE3
St. Lawrence Health System
Shanghai IxCell Biotechnology Co., LTD — PHASE1
Huilan Zhang — PHASE2, PHASE3
GlaxoSmithKline — PHASE3
China Medical University Hospital — PHASE1, PHASE2
Boehringer Ingelheim
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs